Company Profile
- Stock Code
- NTRA
- ISIN Code
- US6323071042
- Currency
- US Dollar (USD)
- IPO Date
- 2015-07-02

Natera, Inc., a diagnostics company, engages in the development and commercialization of molecular testing services worldwide. It offers Signatera, a personalized ctDNA blood test for MRD assessment, early recurrence monitoring, and evaluation of treatment response in patients previously diagnosed with cancer; Latitude, a blood-based MRD test for colorectal...